<i>Lacticaseibacillus rhamnosus</i>: A Suitable Candidate for the Construction of Novel Bioengineered Probiotic Strains for Targeted Pathogen Control

Probiotics, with their associated beneficial effects, have gained popularity for the control of foodborne pathogens. Various sources are explored with the intent to isolate novel robust probiotic strains with a broad range of health benefits due to, among other mechanisms, the production of an array...

Full description

Bibliographic Details
Main Authors: Moloko G. Mathipa-Mdakane, Mapitsi S. Thantsha
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Foods
Subjects:
Online Access:https://www.mdpi.com/2304-8158/11/6/785
_version_ 1797471644077260800
author Moloko G. Mathipa-Mdakane
Mapitsi S. Thantsha
author_facet Moloko G. Mathipa-Mdakane
Mapitsi S. Thantsha
author_sort Moloko G. Mathipa-Mdakane
collection DOAJ
description Probiotics, with their associated beneficial effects, have gained popularity for the control of foodborne pathogens. Various sources are explored with the intent to isolate novel robust probiotic strains with a broad range of health benefits due to, among other mechanisms, the production of an array of antimicrobial compounds. One of the shortcomings of these wild-type probiotics is their non-specificity. A pursuit to circumvent this limitation led to the advent of the field of pathobiotechnology. In this discipline, specific pathogen gene(s) are cloned and expressed into a given probiotic to yield a novel pathogen-specific strain. The resultant recombinant probiotic strain will exhibit enhanced species-specific inhibition of the pathogen and its associated infection. Such probiotics are also used as vehicles to deliver therapeutic agents. As fascinating as this approach is, coupled with the availability of numerous probiotics, it brings a challenge with regard to deciding which of the probiotics to use. Nonetheless, it is indisputable that an ideal candidate must fulfil the probiotic selection criteria. This review aims to show how <i>Lacticaseibacillus rhamnosus</i>, a clinically best-studied probiotic, presents as such a candidate. The objective is to spark researchers’ interest to conduct further probiotic-engineering studies using <i>L</i>. <i>rhamnosus</i>, with prospects for the successful development of novel probiotic strains with enhanced beneficial attributes.
first_indexed 2024-03-09T19:51:06Z
format Article
id doaj.art-50669aea49a8442bb5d5f911f3d94596
institution Directory Open Access Journal
issn 2304-8158
language English
last_indexed 2024-03-09T19:51:06Z
publishDate 2022-03-01
publisher MDPI AG
record_format Article
series Foods
spelling doaj.art-50669aea49a8442bb5d5f911f3d945962023-11-24T01:09:52ZengMDPI AGFoods2304-81582022-03-0111678510.3390/foods11060785<i>Lacticaseibacillus rhamnosus</i>: A Suitable Candidate for the Construction of Novel Bioengineered Probiotic Strains for Targeted Pathogen ControlMoloko G. Mathipa-Mdakane0Mapitsi S. Thantsha1Department of Biochemistry, Genetics and Microbiology, University of Pretoria, Pretoria 0002, South AfricaDepartment of Biochemistry, Genetics and Microbiology, University of Pretoria, Pretoria 0002, South AfricaProbiotics, with their associated beneficial effects, have gained popularity for the control of foodborne pathogens. Various sources are explored with the intent to isolate novel robust probiotic strains with a broad range of health benefits due to, among other mechanisms, the production of an array of antimicrobial compounds. One of the shortcomings of these wild-type probiotics is their non-specificity. A pursuit to circumvent this limitation led to the advent of the field of pathobiotechnology. In this discipline, specific pathogen gene(s) are cloned and expressed into a given probiotic to yield a novel pathogen-specific strain. The resultant recombinant probiotic strain will exhibit enhanced species-specific inhibition of the pathogen and its associated infection. Such probiotics are also used as vehicles to deliver therapeutic agents. As fascinating as this approach is, coupled with the availability of numerous probiotics, it brings a challenge with regard to deciding which of the probiotics to use. Nonetheless, it is indisputable that an ideal candidate must fulfil the probiotic selection criteria. This review aims to show how <i>Lacticaseibacillus rhamnosus</i>, a clinically best-studied probiotic, presents as such a candidate. The objective is to spark researchers’ interest to conduct further probiotic-engineering studies using <i>L</i>. <i>rhamnosus</i>, with prospects for the successful development of novel probiotic strains with enhanced beneficial attributes.https://www.mdpi.com/2304-8158/11/6/785<i>Lacticaseibacillus rhamnosus</i>probioticspathobiotechnologyrecombinant probioticspathogen
spellingShingle Moloko G. Mathipa-Mdakane
Mapitsi S. Thantsha
<i>Lacticaseibacillus rhamnosus</i>: A Suitable Candidate for the Construction of Novel Bioengineered Probiotic Strains for Targeted Pathogen Control
Foods
<i>Lacticaseibacillus rhamnosus</i>
probiotics
pathobiotechnology
recombinant probiotics
pathogen
title <i>Lacticaseibacillus rhamnosus</i>: A Suitable Candidate for the Construction of Novel Bioengineered Probiotic Strains for Targeted Pathogen Control
title_full <i>Lacticaseibacillus rhamnosus</i>: A Suitable Candidate for the Construction of Novel Bioengineered Probiotic Strains for Targeted Pathogen Control
title_fullStr <i>Lacticaseibacillus rhamnosus</i>: A Suitable Candidate for the Construction of Novel Bioengineered Probiotic Strains for Targeted Pathogen Control
title_full_unstemmed <i>Lacticaseibacillus rhamnosus</i>: A Suitable Candidate for the Construction of Novel Bioengineered Probiotic Strains for Targeted Pathogen Control
title_short <i>Lacticaseibacillus rhamnosus</i>: A Suitable Candidate for the Construction of Novel Bioengineered Probiotic Strains for Targeted Pathogen Control
title_sort i lacticaseibacillus rhamnosus i a suitable candidate for the construction of novel bioengineered probiotic strains for targeted pathogen control
topic <i>Lacticaseibacillus rhamnosus</i>
probiotics
pathobiotechnology
recombinant probiotics
pathogen
url https://www.mdpi.com/2304-8158/11/6/785
work_keys_str_mv AT molokogmathipamdakane ilacticaseibacillusrhamnosusiasuitablecandidatefortheconstructionofnovelbioengineeredprobioticstrainsfortargetedpathogencontrol
AT mapitsisthantsha ilacticaseibacillusrhamnosusiasuitablecandidatefortheconstructionofnovelbioengineeredprobioticstrainsfortargetedpathogencontrol